Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$263,436.00
Dec 1, 2025
For-profit organization
1019315
1019315
To enhance capability through new in-house processing and quality control equipment.
$30,000.00
Dec 16, 2024
For-profit organization
Development of second-generation autologous hair follicle-derived serum (2.0).
1026138
Acorn Biolabs has recently developed a pioneering autologous stem cell-based serum derived from the hair follicle. This innovative, cell-free product is rich in exosomes, growth factors, and proteins that have demonstrated significant potential in promoting skin rejuvenation and hair growth. The goal of this project is to develop a second generation of this product, building on the success of the initial formulation while enhancing its efficacy, scalability, and use for broader applications.